Valor2022202320242025TTMFlujo de caja de las actividades de inversión-1.64 B-187.6 M-149.9 M-192.7 M-192.7 MFlujo de caja de las actividades financieras252 M-265.8 M48.8 M155.8 M155.8 MFlujo de caja libre744.4 M70.9 M-112.1 M-83 M-83 M
QuidelOrtho Corporation
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs.